AL · South
Birmingham venture capital & startups
Birmingham, Alabama healthcare and marketplace map — Shipt’s Target exit, Acclinate and ArcheHealth raises, UAB spinouts, and local funds that write first checks.
Birmingham is a Southeast healthcare-services build site: UAB research, large health systems, and Blue Cross Blue Shield of Alabama adjacency. We profile Shipt’s $550M Target exit, active digital-health companies (Acclinate, ArcheHealth), UAB-linked Dialytix and TIXiMED, Prosper relocators, and Birmingham funds including First Avenue Ventures, 450 Ventures, Prosper HealthTech, Measured Capital, and Bronze Valley.
Alabama Birmingham only (not Birmingham, UK). Funds matched by headquarters aliases plus curated national capital listed in the related article. Startups matched by hq field (Birmingham, AL) and curated IDs.
Venture firms in Birmingham
Matched from fund headquarters in our directory (alias-based). Dual-HQ firms may appear in more than one city.
| Firm | HQ (directory) | Leads |
|---|---|---|
| First Avenue Ventures | — | |
| 450 Ventures | — | |
| Prosper HealthTech Accelerator | — | |
| Measured Capital | — | |
| Bronze Valley | — | |
| Alabama Futures Fund | — | |
| Define Ventures | — | |
| F-Prime Capital | — | |
| Bessemer Venture Partners | — | |
| General Catalyst | — |
Startups we cover in Birmingham
Matched from startup hq fields. Many profiles still lack HQ — curated lists
in editorial notes fill gaps when verified.
| Startup | One-liner | HQ |
|---|---|---|
| Shipt | — | |
| Acclinate | — | |
| ArcheHealth | — | |
| Dialytix | — | |
| Revella Health | — | |
| TIXiMED | — |
Coverage gaps
-
Innovation Depot programs (Voltage / Boost)
Primary downtown incubator campus — ecosystem home base, not a classic /fund/ VC vehicle
-
Pack Health (historical)
Major Birmingham healthtech exit to Quest (~$123M, 2022); unit later shut by Quest in 2025 — track as history, not an active profile
-
Archimedes Vascular / ImmPrev Bio
First Avenue life-science portfolio names worth future /startup/ pages when we expand medtech depth
-
Harbert Growth Partners
Birmingham-parent growth equity — different product than seed; optional future /fund/ coverage
Related reading
Birmingham FAQs
Practical answers for founders researching this investor.